File number: 27534
Sign in to comment.
By Linda A Cernichiaro- Espinosa, MD
Asociación para Evitar la Ceguera en México, IAP
Co-author(s): Timothy G Murray, MD, MBA
- Uploaded on Nov 3, 2017.
- Last modified by Linda A Cernichiaro- Espinosa, MD on Dec 1, 2017.
- Appears in
- retinoblastoma, chemoreduction, laser
- Abby Orcutt
- Imaging device
- Fluorescein angiography from three different patients with former R-E stage Vb (ICRB group D). Type 3 regression pattern is observed after cycles of chemoreduction and laser adjuvant therapy. No leakage, staining or pooling is observed by fluorescein angiography.